|
Date: Jan 13, 2012
By:
Contemporary OB/GYN Staff
| Source: Contemporary OB/GYN Special Delivery
|
Women treated for breast cancer with radiotherapy are more likely to develop stenosis in the coronary arteries that are exposed to the greatest amounts of radiation, according to a Swedish study.
Date: Jan 6, 2012
| 
|
NEW YORK (Reuters Health) - In a review of ovarian cancer outcomes, women with diabetes survived longer if they took metformin -- and on progression-free survival the diabetics who used metformin did better even compared to women who didn't have diabetes at all.
Date: Jan 5, 2012
By:
Contemporary OB/GYN Staff
| Source: Contemporary OB/GYN Special Delivery
|
Black and Hispanic women and uninsured or Medicaid-insured women are less likely to receive standard treatment for stage IIIC or IV ovarian cancer, according to a large, multi-institutional cohort study published in Obstetrics and Gynecology (2012;119[1];68-77). MORE
Date: Jan 2, 2012
|
|
NEW YORK (Reuters Health) - Cervical intraepithelial neoplasia grade 1 (CIN 1) found on biopsy provides no information on the risk of progression to CIN 3 beyond that of a human papillomavirus (HPV) infection, researchers report in the December issue of Obstetrics and Gynecology.
Date: Jan 1, 2012
By:
Contemporary OB/GYN Staff
| Source: Contemporary OB/GYN
|
Ovarian stimulation for in vitro fertilization (IVF) may double or even quadruple a woman's risk for an ovarian tumor in the next 15 years, According to a cohort study from the Netherlands involving almost 20,000 women who received IVF treatment between 1983 and 1995 and a comparison group of about 6,000 subfertile women not treated with IVF.
Date: Dec 28, 2011
|
|
NEW YORK (Reuters Health) - The coauthor of a study that helped convince the European Commission on Friday to approve bevacizumab (Avastin) as an initial post-surgical treatment for advanced ovarian cancer predicted that some doctors may be reluctant to use the drug until mortality data become available in 2013.
Date: Dec 24, 2011
|
|
ZURICH (Reuters) - The European Commission has approved Roche's drug Avastin (bevacizumab) for treating newly diagnosed, advanced ovarian cancer, offering new options to sufferers previously limited to surgery and chemotherapy.
Date: Dec 20, 2011
|
|
NEW YORK (Reuters Health) - Uterine fibroids cost the U.S. billions each year in lost work days, pregnancy problems and treatments, a new study finds.
Date: Dec 15, 2011
|
|
NEW YORK (Reuters Health) - Many women are accustomed to getting a pelvic exam every year, and doctors are accustomed to giving them -- but it's unclear if they serve any real purpose in women without any pelvic pain or signs of infection, say the authors of a new report.
|
| 
Practice Tools
